Exchange: NYSEMkt·Updated 09:52 PM EDT
OGEN logo

OGEN Oragenics Inc

$0.4984
$0.0217
(4.17%)
Overnight
Prev Close $0.5201
Mkt Cap$2.34M
Vol12,965.00

About OGEN

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Lakewood Ranch, FL.
54

Neutral Sentiment

How do you feel about OGEN?

Advertisement|Remove ads.